MARATTO

article · Computers in Biology and Medicine

De novo design and bioactivity prediction of mitotic kinesin Eg5 inhibitors using MPNN and LSTM-based transfer learning

In plain language

No abstract is available for this record, so no summary has been generated.

Research topics

  • Computational Drug Discovery Methods
  • Protein Degradation and Inhibitors
  • Bioinformatics and Genomic Networks

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1016/j.compbiomed.2025.110672

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.